Showing results (21-30 of 73) with videos related to
Sort By:
Pageof 8
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
New hydroxypyridinone iron-chelators as potential anti-neurodegenerative drugsDaniela Arduino, Daniel Silva, Sandra M Cardoso, et al.CNS & Neurological Disorders Drug Targets|August 26, 2009
Mitochondria as a therapeutic target in Alzheimer's disease and diabetesPaula I Moreira, Sandra M Cardoso, Cláudia M Pereira, et al.Journal of Alzheimer'S Disease : JAD|February 26, 2010
ER stress-mediated apoptotic pathway induced by Abeta peptide requires the presence of functional mitochondriaRui O Costa, Elisabete Ferreiro, Sandra M Cardoso, et al.Neurobiology of Disease|December 26, 2009
Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathologyA Raquel Esteves, Daniela M Arduíno, Russell H Swerdlow, et al.Antioxidants & Redox Signaling|February 27, 2020
The Mitochondrial Ribosome: A World of Opportunities for Mitochondrial Dysfunction Toward Parkinson's DiseaseAna Mafalda Gonçalves, Ana Raquel Pereira-Santos, Ana Raquel Esteves, et al.Aging Cell|June 26, 2023
Reduction of class I histone deacetylases ameliorates ER-mitochondria cross-talk in Alzheimer's diseaseDaniela Marinho, Ildete Luísa Ferreira, Ricardo Lorenzoni, et al.Biochimica Et Biophysica Acta|September 3, 2013
Activation of the endoplasmic reticulum stress response by the amyloid-beta 1-40 peptide in brain endothelial cellsAna Catarina R G Fonseca, Elisabete Ferreiro, Catarina R Oliveira, et al.Neurotoxicity Research|March 28, 2008
Calpain-mediated MPP+ toxicity in mitochondrial DNA depleted cellsA Filipa Domingues, A Raquel F Esteves, Russell H Swerdlow, et al.Chemical Biology & Drug Design|August 11, 2015
New Tacrine Hybrids with Natural-Based Cysteine Derivatives as Multitargeted Drugs for Potential Treatment of Alzheimer's DiseaseRangappa S Keri, Catarina Quintanova, Sílvia Chaves, et al.European Journal of Medicinal Chemistry|February 22, 2018
Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's diseaseAsha Hiremathad, Rangappa S Keri, A Raquel Esteves, et al.Pageof 8